The management of thrombotic lesions in the cardiac catheterization laboratory

Area of Science:

• Cardiology
• Interventional Cardiology
• Thrombosis Research

Background:

• Acute coronary syndromes (ACS) are primarily caused by plaque rupture and superimposed thrombosis.
• Angiography often underestimates thrombus presence, but detected thrombi are poor prognostic indicators, with size correlating to risk.
• While percutaneous coronary intervention (PCI) is a preferred strategy for ST-elevation myocardial infarction (STEMI) and other ACS, thrombi can impede its benefits through embolization.

Purpose of the Study:

• To review the impact of thrombus on ACS management and outcomes.
• To evaluate the efficacy of various interventions in reducing thrombus burden and improving procedural success.
• To discuss the role of adjunctive therapies and devices in PCI for ACS.

Main Methods:

• Review of current literature on ACS pathophysiology, diagnosis, and treatment strategies.
• Analysis of the impact of thrombus on PCI outcomes and patient prognosis.
• Evaluation of antiplatelet therapies, aspiration thrombectomy, embolic protection devices, and mechanical thrombectomy.

Main Results:

• Glycoprotein IIb/IIIa inhibitors and manual aspiration thrombectomy prior to PCI in STEMI reduce thrombus size, improve myocardial perfusion, and enhance ventricular function.
• Manual aspiration improves myocardial flow, reduces distal embolization, and increases survival in STEMI.
• Distal embolic protection devices and standard mechanical thrombectomy show limited clinical benefits; rheolytic thrombectomy may be useful for large thrombi in large vessels.

Conclusions:

• Thrombus burden significantly impacts ACS management and PCI outcomes.
• Antiplatelet therapy and manual aspiration are effective in mitigating the negative effects of thrombus.
• Further research into optimal thrombectomy strategies is warranted, with rheolytic thrombectomy showing potential for specific cases.